Patent · US Expired

Factor Vlla inhibitors

US6287794A · kind A · utility

4Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 1999
Grant dateSep 11, 2001
Priority date
Expiry dateSep 14, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/105831
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds and pharmaceutical composition, their preparation, and their use, having a antithrombotic effect through reversible inhibition of activated blood coagulation factor VIIa "FVIIa".

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.